世界最新医学信息文摘(连续型电子期刊)
世界最新醫學信息文摘(連續型電子期刊)
세계최신의학신식문적(련속형전자기간)
World Latest Medicine Information
2014年
26期
44-45
,共2页
高渗盐水%雾化吸入%毛细支气管炎
高滲鹽水%霧化吸入%毛細支氣管炎
고삼염수%무화흡입%모세지기관염
hypertonic saline%aerosol inhalation%capillary bronchitis
目的:观察高渗盐水雾化吸入治疗婴幼儿毛细支气管炎的疗效。方法100例毛细支气管炎患儿随机分为治疗组和对照组,在给予静脉输液、抗生素和祛痰剂等治疗基础上,治疗组在入院24h、48h、72h内分别给予4ml3℅的高渗盐水q4、q6、q8雾化吸入;对照组给予4ml0.9℅的生理盐水以相同的方式雾化吸入。观察两组咳嗽,憋喘和肺部啰音消失时间,对比两组住院时间。结果治疗组平均治愈率为90℅,明显高与对照组70℅的治愈率;而住院时间治疗组平均为7.2±1.8天,明显低于对照组8.2±2.1天,两组对比均有显著性差异(P<0.05);两组出现的副作用发生率治疗组为12℅,对照组为10℅,两组对比无显著性差异(P>0.05)。结论高渗盐水雾化吸入治疗婴幼儿毛细支气管炎是安全,有效的方法。
目的:觀察高滲鹽水霧化吸入治療嬰幼兒毛細支氣管炎的療效。方法100例毛細支氣管炎患兒隨機分為治療組和對照組,在給予靜脈輸液、抗生素和祛痰劑等治療基礎上,治療組在入院24h、48h、72h內分彆給予4ml3℅的高滲鹽水q4、q6、q8霧化吸入;對照組給予4ml0.9℅的生理鹽水以相同的方式霧化吸入。觀察兩組咳嗽,憋喘和肺部啰音消失時間,對比兩組住院時間。結果治療組平均治愈率為90℅,明顯高與對照組70℅的治愈率;而住院時間治療組平均為7.2±1.8天,明顯低于對照組8.2±2.1天,兩組對比均有顯著性差異(P<0.05);兩組齣現的副作用髮生率治療組為12℅,對照組為10℅,兩組對比無顯著性差異(P>0.05)。結論高滲鹽水霧化吸入治療嬰幼兒毛細支氣管炎是安全,有效的方法。
목적:관찰고삼염수무화흡입치료영유인모세지기관염적료효。방법100례모세지기관염환인수궤분위치료조화대조조,재급여정맥수액、항생소화거담제등치료기출상,치료조재입원24h、48h、72h내분별급여4ml3℅적고삼염수q4、q6、q8무화흡입;대조조급여4ml0.9℅적생리염수이상동적방식무화흡입。관찰량조해수,별천화폐부라음소실시간,대비량조주원시간。결과치료조평균치유솔위90℅,명현고여대조조70℅적치유솔;이주원시간치료조평균위7.2±1.8천,명현저우대조조8.2±2.1천,량조대비균유현저성차이(P<0.05);량조출현적부작용발생솔치료조위12℅,대조조위10℅,량조대비무현저성차이(P>0.05)。결론고삼염수무화흡입치료영유인모세지기관염시안전,유효적방법。
Objective to investigate the effect of hypertonic saline through aerosol inhalation in the treatment of infants with capillary bronchiolitis.Methods 100 cases with bronchiolitis were randomly divided into two groups, treatment group and control group. on the base treatment of venous transfusion, antibiotic and expectorant, the treatment group patients were nebulized with 3℅ hypertonic saline 4ml q4、q6 and q8 on the admission day of 24h、48h、72h, respectively, while the control group patients were nebulized with 0.9℅ normal saline 4ml in the same way like in the treatment group. The time of symptoms disappeared such as cough, wheezing and moist in the lungs were observed and hospitalization days were compared in the two groups.Results The overall efifcacy rate of the treatment group was 90℅, higher than that of the control group (70℅) (P<0.05); and in the treatment group the average inhosptalization days were 7.2±1.8d, shorter than that of the control group(8.2±2.1) d (P<0.05). The occurance of side effect in the treatment group was 12℅, there was no signiifcant difference compared with the control group (10℅).Conclusion nebulized hypertonic saline in the treatment of infants with bronchiolitis is a safe and effective way.